Our Team

Marc Guillet
Executive Director / President

Marc started A Foundation Building Strength in February of 2008 to help his daughter Ava and all patients with Nemaline Myopathy.

Marc is the CEO of Agile Physical Therapy, a company he founded in July of 2002. He is also the director of physical therapy for the Palo Alto Medical Foundation. Marc is on the advisory board for two medical device companies involving technological advances in treatment and rehabilitation of orthopedic and neurologic advances.

Marc is a Board-certified Orthopedic Specialist. His affiliations include: American Physical Therapy Association, National Athletic Training Association, and Orthopedic and Sports Sections of the American Physical Therapy Association. He graduated from Columbia University, New York 1991.

Hali Weiss, MD
Advisor

Dr. Weiss uses her experience to help A Foundation Building Strength select research projects for funding, as well as provide ongoing medical guidance to the Foundation.  Hali is a Clinical Instructor and Staff Physician at Stanford Lucille Packard Children’s Hospital Department of Neonatology. She is also an attending physician in the High Risk Infant Follow-Up Clinic.

Following a General Pediatrics residency at the Mount Sinai Medical Center in New York, Dr. Weiss completed a fellowship in Neonatology at the Cardiovascular Research Institute at UCSF. As a fellow, she conducted several neonatal outcome studies and her clinical experience in developmental follow-up clinics dates back to her residency. Dr. Weiss worked for several years as a clinical neonatologist at LPCH, Santa Clara Valley Medical Center, and El Camino Hospital before joining the high risk infant follow-up team at LPCH in 2003.

Elyse Stratton
Advisor

Elyse has worked on the clinical and commercial development of companion diagnostic tests from the pharmaceutical, laboratory and patient perspective. She joined Genentech in their diagnostic operations group and was responsible for running an advisory board on EGFR testing methodologies; she worked at Monogram Biosciences on the global launch of an HIV companion diagnostic for Pfizer.  Elyse has experience in market analytics and planning, commercial operations and diagnostic strategy. She currently consults on strategic and commercial issues for large and small biotech companies, as well as the VC community. She earned her MA in International Relations and Economics from Johns Hopkins University and her MPhil in Bioscience Enterprise from University of Cambridge.

KT Moortgat, PhD
Advisor

KT Moortgat is an enabler of technology translation and commercialization, through startup incubation, investment decision making, and corporate partnering and licensing.  For several years, she has worked as an executive-level consultant leading business development, strategy, and licensing for life science companies in precision medicine, and microbiome and oncology therapeutics. Prior, she was a partner at the venture capital firm Mohr Davidow Ventures (MDV) where she was responsible for sourcing and evaluating investments in life science and energy companies, and supported personalized medicine portfolio companies with product strategy and corporate development.  She led university partnering and engaged key opinion leaders and technology innovators through the MDV Innovators Award.

Dr. Moortgat is the founder and former director of the hub of entrepreneurship at the University of California San Francisco and the QB3 Institute, which established a university-based core of resources and services for entrepreneurs in addition to mentoring, training and networking with investors and industry leaders. She holds doctoral and Master’s degrees from University of California San Diego, and an undergraduate physics degree from UC Berkeley.

Thomas Hyde, MD PhD
Advisor

Thomas M. Hyde, M.D., Ph.D., is the Chief Operating Officer of the Lieber Institute for Brain Development. As such, he directly oversees all functions of the Central Administrative Division, including personnel, finance, information technology, facilities, contracts, and affiliations with outside organizations. In addition to his administrative portfolio, Dr. Hyde manages the Institute’s collection of postmortem human brain samples.  His research focuses on changes in GABA signaling across the stages of normal development and in major psychiatric diseases. Dr. Hyde attended the University of Pennsylvania from 1974–1984. He received a B.A. in Biology in 1978, graduating summa cum laude. He received a joint M.D.-Ph.D. in 1984, with a Ph.D. from the Department of Anatomy. While in this combined degree program, he was the recipient of a University Scholars Award from Penn, and a Medical Scientist Training Program Scholarship from the NIH. He served a general medical internship at the Penn Presbyterian Medical Center from 1984–1985, followed by a neurology residency at Stanford University from 1985–1988. He served as Chief Resident in Neurology the final year of his residency. After leaving California, Dr. Hyde worked in the Clinical Brain Disorders Branch (CBDB) of the intramural program of the National Institute of Mental Health (NIMH). He ran the Neurology Consultation Clinics at St. Elizabeth’s Hospital under the auspices of the NIMH from 1988–1996. From 1996–2010, he worked full-time in the Section on Neuropathology in the CBDB, developing the world’s largest collection of postmortem human brains dedicated to neuropsychiatric disease in general, and schizophrenia in particular.

Mark Eller, PhD
Advisor

Mark G. Eller, Ph.D., is a drug development executive with twenty + years experience in pharmaceutical R&D; including leadership of other VP’s and organizations/departments of 50+ employees. Dr. Eller has extensive experience in pre-clinical studies and the design, execution, analysis and reporting of Phase 1, 2 and 3 clinical trials in the U.S. and Europe. His experience also includes preparation of multiple regulatory filings in U.S., Canada and Europe including IND, MAA, NDA, and CTD submissions leading to approvals. Mark has participated in 6 FDA Advisory Committee meetings, twice as a primary presenter. He is co-inventor on 4 patents in drug discovery and development.

Dana Guillett

Dana graduated from University of Southern California with a B.S. in Business Administration. She thrived as a recruiter in the area of Human Resources for a variety of companies in the fields of Entertainment, Investment Banking and Technology. In 2002, Dana partnered with her husband in starting Agile PT. When her youngest child of three was born with NM, Dana founded A Foundation Building Strength and invests her time in working to better the lives of those affected by this rare disease.

Aletha Coleman, J.D.

For the last 20 years, Aletha Leong Coleman has focused on serving non-profit organizations in the Palo Alto, CA area in various board capacities, including establishing board governance, chairing finance, audit, development committees, and chairing specific development efforts.  Aletha was born and raised in Honolulu, Hawaii, graduating from the University of Hawaii in 1978 with a BA (with Honors) in Medieval Studies. She also attended Hastings College of the Law at U.C. Berkeley, and is a (retired) attorney and CPA.

Annette Bialson, J.D.

Annette is a lawyer with extensive experience with non-profit foundations. She is currently Chair of the Board of Directors for Avenidas and is on the finance committee of the Northern California Arthritis Foundation.  Annette has over 20 years of experience practicing law in Silicon Valley. She is one of the founders of Bialson, Bergen & Schwab – a law firm specializing in domestic and international commercial law transactions of publicly traded companies.Annette received her J.D. from Stanford University.

Hali Weiss, M.D.

Dr. Weiss uses her experience to help A Foundation Building Strength select research projects for funding, as well as provide ongoing medical guidance to the Foundation.  Hali is a Clinical Instructor and Staff Physician at Stanford Lucille Packard Children’s Hospital Department of Neonatology. She is also an attending physician in the High Risk Infant Follow-Up Clinic.

Following a General Pediatrics residency at the Mount Sinai Medical Center in New York, Dr. Weiss completed a fellowship in Neonatology at the Cardiovascular Research Institute at UCSF. As a fellow, she conducted several neonatal outcome studies and her clinical experience in developmental follow-up clinics dates back to her residency. Dr. Weiss worked for several years as a clinical neonatologist at LPCH, Santa Clara Valley Medical Center, and El Camino Hospital before joining the high risk infant follow-up team at LPCH in 2003.